Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of respiratory infections in children. Palivizumab (PZ) is the only RSV-specific immunoprophylaxis approved by the U.S. Food and Drug Administration. Mutations leading to amino acid substitutions in the PZ binding site of the RSV F prote...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Virol
Main Authors: Oliveira, Danielle B.L., Iwane, Marika K., Prill, Mila M., Weinberg, Geoffrey A., Williams, John V., Griffin, Marie R., Szilagyi, Peter G., Edwards, Kathryn M., Staat, Mary A., Hall, Caroline B., Durigon, Edison L., Erdman, Dean D.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172275/
https://ncbi.nlm.nih.gov/pubmed/25766983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2015.01.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados